APO Research
Talk to an analyst

APO RESEARCH · REPORT

Codeine

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Selected research

Industry Growth & Trends

Global Codeine Industry Growth and Trends Forecast to 2032

26 December 2025112 pages

Choose your research edition.

Industry ResearchCodeine Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Codeine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Codeine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Codeine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Codeine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Codeine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Codeine market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Codeine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Codeine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Codeine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Codeine Market by Company

Taiji

Mallinckrodt

TEVA

Johnson & Johnson

Medreich

Sanofi Aventis

Cipla

Hikma

Pharmaceutical Associates

Novartis

Apotex

Mylan

Aristo Pharma GmbH

Lannett Company

Laboratoire Riva

Codeine Segment by Ingredient

Single-ingredient Codeine

Multi-ingredient Medications

Codeine Segment by Application

Narcotic Analgesic

Antitussive

Others

Codeine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Codeine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Codeine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Codeine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single-ingredient Codeine Table 2. Major Company of Multi-ingredient Medications Table 3. Global Codeine Sales by Ingredient (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Codeine Sales by Ingredient (2021-2026) & (M Units) Table 5. Global Codeine Sales Market Share in Volume by Ingredient (2021-2026) Table 6. Global Codeine Sales by Ingredient (2021-2026) & (US$ Million) Table 7. Global Codeine Sales Market Share in Value by Ingredient (2021-2026) Table 8. Global Codeine Price by Ingredient (2021-2026) & (USD/Unit) Table 9. Global Codeine Sales by Ingredient (2027-2032) & (M Units) Table 10. Global Codeine Sales Market Share in Volume by Ingredient (2027-2032) Table 11. Global Codeine Sales by Ingredient (2027-2032) & (US$ Million) Table 12. Global Codeine Sales Market Share in Value by Ingredient (2027-2032) Table 13. Global Codeine Price by Ingredient (2027-2032) & (USD/Unit) Table 14. North America Codeine Sales by Ingredient (2021-2026) & (M Units) Table 15. North America Codeine Sales by Ingredient (2021-2026) & (US$ Million) Table 16. Europe Codeine Sales by Ingredient (2021-2026) & (M Units) Table 17. Europe Codeine Sales by Ingredient (2021-2026) & (US$ Million) Table 18. Asia-Pacific Codeine Sales by Ingredient (2021-2026) & (M Units) Table 19. Asia-Pacific Codeine Sales by Ingredient (2021-2026) & (US$ Million) Table 20. Latin America Codeine Sales by Ingredient (2021-2026) & (M Units) Table 21. Latin America Codeine Sales by Ingredient (2021-2026) & (US$ Million) Table 22. Middle East and Africa Codeine Sales by Ingredient (2021-2026) & (M Units) Table 23. Middle East and Africa Codeine Sales by Ingredient (2021-2026) & (US$ Million) Table 24. Codeine Industry Trends Table 25. Codeine Industry Drivers Table 26. Codeine Industry Opportunities and Challenges Table 27. Codeine Industry Restraints Table 28. Global Codeine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Codeine Revenue Market Share by Company (2021-2026) Table 30. Global Codeine Sales by Company (2021-2026) & (M Units) Table 31. Global Codeine Sales Share by Company (2021-2026) Table 32. Global Codeine Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Codeine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Codeine Major Company Production Sites and Headquarters Table 35. Global Codeine Company, Product Type & Application Table 36. Global Codeine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Codeine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Codeine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Codeine Sales by Region (2021-2026) & (M Units) Table 41. Global Codeine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Codeine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Codeine Sales Market Share in Value by Region (2021-2026) Table 44. Global Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Codeine Sales by Region (2027-2032) & (M Units) Table 46. Global Codeine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Codeine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Codeine Sales Market Share in Value by Region (2027-2032) Table 49. Global Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Codeine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Codeine Sales by Application (2021-2026) & (M Units) Table 52. Global Codeine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Codeine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Codeine Sales Market Share in Value by Application (2021-2026) Table 55. Global Codeine Price by Application (2021-2026) & (USD/Unit) Table 56. Global Codeine Sales by Application (2027-2032) & (M Units) Table 57. Global Codeine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Codeine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Codeine Sales Market Share in Value by Application (2027-2032) Table 60. Global Codeine Price by Application (2027-2032) & (USD/Unit) Table 61. North America Codeine Sales by Application (2021-2026) & (M Units) Table 62. North America Codeine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Codeine Sales by Application (2021-2026) & (M Units) Table 64. Europe Codeine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Codeine Sales by Application (2021-2026) & (M Units) Table 66. Asia-Pacific Codeine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Codeine Sales by Application (2021-2026) & (M Units) Table 68. Latin America Codeine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Codeine Sales by Application (2021-2026) & (M Units) Table 70. Middle East and Africa Codeine Sales by Application (2021-2026) & (US$ Million) Table 71. Taiji Company Information Table 72. Taiji Business Overview Table 73. Taiji Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Taiji Codeine Product Portfolio Table 75. Taiji Recent Development Table 76. Mallinckrodt Company Information Table 77. Mallinckrodt Business Overview Table 78. Mallinckrodt Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Mallinckrodt Codeine Product Portfolio Table 80. Mallinckrodt Recent Development Table 81. TEVA Company Information Table 82. TEVA Business Overview Table 83. TEVA Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. TEVA Codeine Product Portfolio Table 85. TEVA Recent Development Table 86. Johnson & Johnson Company Information Table 87. Johnson & Johnson Business Overview Table 88. Johnson & Johnson Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Johnson & Johnson Codeine Product Portfolio Table 90. Johnson & Johnson Recent Development Table 91. Medreich Company Information Table 92. Medreich Business Overview Table 93. Medreich Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Medreich Codeine Product Portfolio Table 95. Medreich Recent Development Table 96. Sanofi Aventis Company Information Table 97. Sanofi Aventis Business Overview Table 98. Sanofi Aventis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Sanofi Aventis Codeine Product Portfolio Table 100. Sanofi Aventis Recent Development Table 101. Cipla Company Information Table 102. Cipla Business Overview Table 103. Cipla Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Cipla Codeine Product Portfolio Table 105. Cipla Recent Development Table 106. Hikma Company Information Table 107. Hikma Business Overview Table 108. Hikma Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Hikma Codeine Product Portfolio Table 110. Hikma Recent Development Table 111. Pharmaceutical Associates Company Information Table 112. Pharmaceutical Associates Business Overview Table 113. Pharmaceutical Associates Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Pharmaceutical Associates Codeine Product Portfolio Table 115. Pharmaceutical Associates Recent Development Table 116. Novartis Company Information Table 117. Novartis Business Overview Table 118. Novartis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Novartis Codeine Product Portfolio Table 120. Novartis Recent Development Table 121. Apotex Company Information Table 122. Apotex Business Overview Table 123. Apotex Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Apotex Codeine Product Portfolio Table 125. Apotex Recent Development Table 126. Mylan Company Information Table 127. Mylan Business Overview Table 128. Mylan Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Mylan Codeine Product Portfolio Table 130. Mylan Recent Development Table 131. Aristo Pharma GmbH Company Information Table 132. Aristo Pharma GmbH Business Overview Table 133. Aristo Pharma GmbH Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. Aristo Pharma GmbH Codeine Product Portfolio Table 135. Aristo Pharma GmbH Recent Development Table 136. Lannett Company Company Information Table 137. Lannett Company Business Overview Table 138. Lannett Company Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. Lannett Company Codeine Product Portfolio Table 140. Lannett Company Recent Development Table 141. Laboratoire Riva Company Information Table 142. Laboratoire Riva Business Overview Table 143. Laboratoire Riva Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 144. Laboratoire Riva Codeine Product Portfolio Table 145. Laboratoire Riva Recent Development Table 146. North America Codeine Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 147. North America Codeine Sales by Country (2021-2026) & (M Units) Table 148. North America Codeine Sales Market Share by Country (2021-2026) Table 149. North America Codeine Sales Forecast by Country (2027-2032) & (M Units) Table 150. North America Codeine Sales Market Share Forecast by Country (2027-2032) Table 151. North America Codeine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Codeine Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Codeine Market Share by Country (2021-2026) Table 154. North America Codeine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Codeine Market Share Forecast by Country (2027-2032) Table 156. Europe Codeine Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 157. Europe Codeine Sales by Country (2021-2026) & (M Units) Table 158. Europe Codeine Sales Market Share by Country (2021-2026) Table 159. Europe Codeine Sales Forecast by Country (2027-2032) & (M Units) Table 160. Europe Codeine Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Codeine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Codeine Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Codeine Market Share by Country (2021-2026) Table 164. Europe Codeine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Codeine Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Codeine Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Codeine Sales by Country (2021-2026) & (M Units) Table 168. Asia-Pacific Codeine Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Codeine Sales Forecast by Country (2027-2032) & (M Units) Table 170. Asia-Pacific Codeine Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Codeine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Codeine Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Codeine Market Share by Country (2021-2026) Table 174. Asia-Pacific Codeine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Codeine Market Share Forecast by Country (2027-2032) Table 176. Latin America Codeine Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 177. Latin America Codeine Sales by Country (2021-2026) & (M Units) Table 178. Latin America Codeine Sales Market Share by Country (2021-2026) Table 179. Latin America Codeine Sales Forecast by Country (2027-2032) & (M Units) Table 180. Latin America Codeine Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Codeine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Codeine Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Codeine Market Share by Country (2021-2026) Table 184. Latin America Codeine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Codeine Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Codeine Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Codeine Sales by Country (2021-2026) & (M Units) Table 188. Middle East and Africa Codeine Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Codeine Sales Forecast by Country (2027-2032) & (M Units) Table 190. Middle East and Africa Codeine Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Codeine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Codeine Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Codeine Market Share by Country (2021-2026) Table 194. Middle East and Africa Codeine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Codeine Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Codeine Distributors List Table 199. Codeine Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Codeine Image Figure 2. Global Codeine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Codeine Market Size (2021-2032) & (US$ Million) Figure 4. Global Codeine Sales (2021-2032) & (M Units) Figure 5. Single-ingredient Codeine Image Figure 6. Global Single-ingredient Codeine Sales YoY Growth (2021-2032) & (M Units) Figure 7. Multi-ingredient Medications Image Figure 8. Global Multi-ingredient Medications Sales YoY Growth (2021-2032) & (M Units) Figure 9. Global Codeine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Codeine Market Share by Type 2025 VS 2032 Figure 11. North America Codeine Sales Market Share in Volume by Type in 2025 Figure 12. North America Codeine Sales Market Share in Value by Type in 2025 Figure 13. Europe Codeine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Codeine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Codeine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Codeine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Codeine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Codeine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Codeine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Codeine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Codeine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Narcotic Analgesic Image Figure 24. Global Narcotic Analgesic Sales YoY Growth (2021-2032) & (M Units) Figure 25. Antitussive Image Figure 26. Global Antitussive Sales YoY Growth (2021-2032) & (M Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 29. Global Codeine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Codeine Market Share by Application 2025 VS 2032 Figure 31. North America Codeine Sales Market Share in Volume by Application in 2025 Figure 32. North America Codeine Sales Market Share in Value by Application in 2025 Figure 33. Europe Codeine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Codeine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Codeine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Codeine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Codeine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Codeine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Codeine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Codeine Sales Market Share in Value by Application in 2025 Figure 41. North America Codeine Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 42. North America Codeine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Codeine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Codeine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Codeine Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. Europe Codeine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Codeine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Codeine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Codeine Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Asia-Pacific Codeine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Codeine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Codeine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Codeine Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Latin America Codeine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Codeine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Codeine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Codeine Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Middle East and Africa Codeine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Codeine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Codeine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Codeine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Codeine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Single-ingredient Codeine
  • Multi-ingredient Medications
Applications
  • Narcotic Analgesic
  • Antitussive
  • Others
Companies covered
  • Taiji
  • Mallinckrodt
  • TEVA
  • Johnson & Johnson
  • Medreich
  • Sanofi Aventis
  • Cipla
  • Hikma
  • Pharmaceutical Associates
  • Novartis
  • Apotex
  • Mylan
  • Aristo Pharma GmbH
  • Lannett Company
  • Laboratoire Riva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Codeine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Codeine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Codeine Market by Ingredient
  6. 1.3.1 Single-ingredient Codeine
  7. 1.3.2 Multi-ingredient Medications
  8. 1.4 Global Codeine Market Size by Ingredient
  9. 1.4.1 Global Codeine Market Size Overview by Ingredient (2021-2032)
  10. 1.4.2 Global Codeine Historic Market Size Review by Ingredient (2021-2026)
  11. 1.4.3 Global Codeine Forecasted Market Size by Ingredient (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Codeine Sales Breakdown by Ingredient (2021-2026)
  14. 1.5.2 Europe Codeine Sales Breakdown by Ingredient (2021-2026)
  15. 1.5.3 Asia-Pacific Codeine Sales Breakdown by Ingredient (2021-2026)
  16. 1.5.4 South America Codeine Sales Breakdown by Ingredient (2021-2026)
  17. 1.5.5 Middle East and Africa Codeine Sales Breakdown by Ingredient (2021-2026)
2 Global Market Dynamics
  1. 2.1 Codeine Industry Trends
  2. 2.2 Codeine Industry Drivers
  3. 2.3 Codeine Industry Opportunities and Challenges
  4. 2.4 Codeine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Codeine Revenue (2021-2026)
  2. 3.2 Global Top Players by Codeine Sales (2021-2026)
  3. 3.3 Global Top Players by Codeine Price (2021-2026)
  4. 3.4 Global Codeine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Codeine Major Company Production Sites & Headquarters
  6. 3.6 Global Codeine Company, Product Type & Application
  7. 3.7 Global Codeine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Codeine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Codeine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Codeine Tier 1, Tier 2, and Tier 3
4 Codeine Regional Status and Outlook
  1. 4.1 Global Codeine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Codeine Historic Market Size by Region
  3. 4.2.1 Global Codeine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Codeine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Codeine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Codeine Forecasted Market Size by Region
  7. 4.3.1 Global Codeine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Codeine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Codeine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Codeine by Application
  1. 5.1 Codeine Market by Application
  2. 5.1.1 Narcotic Analgesic
  3. 5.1.2 Antitussive
  4. 5.1.3 Others
  5. 5.2 Global Codeine Market Size by Application
  6. 5.2.1 Global Codeine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Codeine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Codeine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Codeine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Codeine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Codeine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Codeine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Codeine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Taiji
  2. 6.1.1 Taiji Company Information
  3. 6.1.2 Taiji Business Overview
  4. 6.1.3 Taiji Codeine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Taiji Codeine Product Portfolio
  6. 6.1.5 Taiji Recent Developments
  7. 6.2 Mallinckrodt
  8. 6.2.1 Mallinckrodt Company Information
  9. 6.2.2 Mallinckrodt Business Overview
  10. 6.2.3 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mallinckrodt Codeine Product Portfolio
  12. 6.2.5 Mallinckrodt Recent Developments
  13. 6.3 TEVA
  14. 6.3.1 TEVA Company Information
  15. 6.3.2 TEVA Business Overview
  16. 6.3.3 TEVA Codeine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 TEVA Codeine Product Portfolio
  18. 6.3.5 TEVA Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Codeine Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Medreich
  26. 6.5.1 Medreich Company Information
  27. 6.5.2 Medreich Business Overview
  28. 6.5.3 Medreich Codeine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Medreich Codeine Product Portfolio
  30. 6.5.5 Medreich Recent Developments
  31. 6.6 Sanofi Aventis
  32. 6.6.1 Sanofi Aventis Company Information
  33. 6.6.2 Sanofi Aventis Business Overview
  34. 6.6.3 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi Aventis Codeine Product Portfolio
  36. 6.6.5 Sanofi Aventis Recent Developments
  37. 6.7 Cipla
  38. 6.7.1 Cipla Company Information
  39. 6.7.2 Cipla Business Overview
  40. 6.7.3 Cipla Codeine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cipla Codeine Product Portfolio
  42. 6.7.5 Cipla Recent Developments
  43. 6.8 Hikma
  44. 6.8.1 Hikma Company Information
  45. 6.8.2 Hikma Business Overview
  46. 6.8.3 Hikma Codeine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hikma Codeine Product Portfolio
  48. 6.8.5 Hikma Recent Developments
  49. 6.9 Pharmaceutical Associates
  50. 6.9.1 Pharmaceutical Associates Company Information
  51. 6.9.2 Pharmaceutical Associates Business Overview
  52. 6.9.3 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pharmaceutical Associates Codeine Product Portfolio
  54. 6.9.5 Pharmaceutical Associates Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Codeine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Codeine Product Portfolio
  60. 6.10.5 Novartis Recent Developments
  61. 6.11 Apotex
  62. 6.11.1 Apotex Company Information
  63. 6.11.2 Apotex Business Overview
  64. 6.11.3 Apotex Codeine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Apotex Codeine Product Portfolio
  66. 6.11.5 Apotex Recent Developments
  67. 6.12 Mylan
  68. 6.12.1 Mylan Company Information
  69. 6.12.2 Mylan Business Overview
  70. 6.12.3 Mylan Codeine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Mylan Codeine Product Portfolio
  72. 6.12.5 Mylan Recent Developments
  73. 6.13 Aristo Pharma GmbH
  74. 6.13.1 Aristo Pharma GmbH Company Information
  75. 6.13.2 Aristo Pharma GmbH Business Overview
  76. 6.13.3 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Aristo Pharma GmbH Codeine Product Portfolio
  78. 6.13.5 Aristo Pharma GmbH Recent Developments
  79. 6.14 Lannett Company
  80. 6.14.1 Lannett Company Company Information
  81. 6.14.2 Lannett Company Business Overview
  82. 6.14.3 Lannett Company Codeine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Lannett Company Codeine Product Portfolio
  84. 6.14.5 Lannett Company Recent Developments
  85. 6.15 Laboratoire Riva
  86. 6.15.1 Laboratoire Riva Company Information
  87. 6.15.2 Laboratoire Riva Business Overview
  88. 6.15.3 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Laboratoire Riva Codeine Product Portfolio
  90. 6.15.5 Laboratoire Riva Recent Developments
7 North America by Country
  1. 7.1 North America Codeine Sales by Country
  2. 7.1.1 North America Codeine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Codeine Sales by Country (2021-2026)
  4. 7.1.3 North America Codeine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Codeine Market Size by Country
  6. 7.2.1 North America Codeine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Codeine Market Size by Country (2021-2026)
  8. 7.2.3 North America Codeine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Codeine Sales by Country
  2. 8.1.1 Europe Codeine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Codeine Sales by Country (2021-2026)
  4. 8.1.3 Europe Codeine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Codeine Market Size by Country
  6. 8.2.1 Europe Codeine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Codeine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Codeine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Codeine Sales by Country
  2. 9.1.1 Asia-Pacific Codeine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Codeine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Codeine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Codeine Market Size by Country
  6. 9.2.1 Asia-Pacific Codeine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Codeine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Codeine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Codeine Sales by Country
  2. 10.1.1 South America Codeine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Codeine Sales by Country (2021-2026)
  4. 10.1.3 South America Codeine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Codeine Market Size by Country
  6. 10.2.1 South America Codeine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Codeine Market Size by Country (2021-2026)
  8. 10.2.3 South America Codeine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Codeine Sales by Country
  2. 11.1.1 Middle East and Africa Codeine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Codeine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Codeine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Codeine Market Size by Country
  6. 11.2.1 Middle East and Africa Codeine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Codeine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Codeine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Codeine Value Chain Analysis
  2. 12.1.1 Codeine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Codeine Production Mode & Process
  7. 12.2 Codeine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Codeine Distributors
  10. 12.2.3 Codeine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst